|
美托洛尔对急性心肌梗塞的退热效应研究与临床意义 |
| |
in acute mycardial infarction: a randomised placebo-controlled international trial. Eur Heart J, 1985,6:199-226.
2 Viskin S, Kitzis I, Lev E, et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. J Am Coll Cardiol, 1995,25:1327-1332.
3 Barron HV, Viskin S, Lundstrom RJ, et al. Effect of β-adrenergic blocking agents on mortality rate in patients not revascularized after myocardial infarction: Data from alarge HMO. Am Heart J, 1997,134:608-613.
4 Soumerei SB, Mclaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of β-blockers in elderly survivors of acute myocardial infarction. JAMA, 1997,277:115-121.
上一页 [1] [2]
上一个医学论文： 弥散性血管内凝血的病因和发病机制
下一个医学论文： 安慰剂对照观察微粒化非诺贝特对高脂血症患者的临床疗效
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文